OrbiMed raises $3B in new life sciences funds, including $1B+ for Asia
OrbiMed, one of the biggest life science investors in the world, has raised $3 billion across two new funds. OrbiMed’s 10th private equity fund in its flagship series put together “over $1.9 billion” to invest ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.